中国肿瘤生物治疗杂志2016，Vol.23Issue(1)：79-82,4.DOI:10.3872/j.issn.1007-385X.2016.01.013
曲妥珠单抗联合紫杉醇+替吉奥二线治疗HER-2阳性转移性晚期胃癌的疗效
Effect of trastuzumab combined with paclitaxel and S-1 chemotherapy on treating metastatic HER2-positive advanced gastric carcinoma
摘要
关键词
胃癌/曲妥珠单抗/人表皮生长因子受体2/紫杉醇/替吉奥/二线化疗Key words
gastric carcinoma/trastuzumab/human epidermal growth factor receptor-2/paclitaxel/"tegafur gimeracil and oteracil potassium" (S-1)/second-line chemotherapy分类
医药卫生引用本文复制引用
周宁,周洋,唐勇..曲妥珠单抗联合紫杉醇+替吉奥二线治疗HER-2阳性转移性晚期胃癌的疗效[J].中国肿瘤生物治疗杂志,2016,23(1):79-82,4.基金项目
新疆维吾尔自治区自然科学基金资助项目(No.2013211A067) （No.2013211A067）
新疆医科大学科研创新基金资助项目(No.XJC201384).Project supported by the Natural Science Foundation of Xinjiang Uygur Autonomous Region(No.2013211A067),and the Scientific Research Innovation Foundation of Xinjiang Medical University(No.XJC201384) （No.XJC201384）
